Ontoforce develops DISQOVER, a life sciences-specific semantic layer that unifies and enriches biomedical data into a living knowledge graph for pharmaceutical companies. The platform integrates proprietary, licensed, and public datasets through ontology-based knowledge graphs, augmented with over 80 pre-ingested public data sources. DISQOVER enables researchers to query in plain language without SQL expertise, visualize relationships through configurable dashboards, and ground AI outputs with full data provenance and traceable lineage for regulated industries. Founded in 2011 and headquartered in Ghent, Belgium, the company has raised approximately $12.7M in Series B funding. Ontoforce differentiates itself through nearly 15 years of domain expertise, 80 billion triples, 90% faster data access, FAIR-by-design principles, and trusted partnerships with UCB, Merck Healthcare, AstraZeneca, Takeda, and the Princess Maxima Center for Pediatric Oncology.
Ontoforce
Series BOntoforce develops DISQOVER, a life sciences-specific semantic layer that unifies and enriches biomedical data into a living knowledge graph for pharmaceutical companies. The platform integrates proprietary, licensed, and public datasets through ontology-based knowledge graphs, augmented with over 80 pre-ingested public data sources. DISQOVER enables researchers to query in plain language without SQL expertise,…
About
Business model
Business Intelligence > Unstructured Data Analytics > Text Analytics > Internal > File Search,
Big Data Analytics > Data Discovery & Visualization > Discovery > Knowledge Platform,
Enterprise Information Management > Knowledge Management > Semantic Software,
Life Sciences Tech > Research & Development > Drug Informatics > Clinical Data Analysis
Institutional investors
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Full list of active funds — filter by stage, check size, and geography.